Clinical trials Consistent benefits of brentuximab vedotin plus chemotherapy for CD30-positive peripheral T-ce... Read more
Clinical trials ADDING ROMIDEPSIN TO CHOP IN FIRST-LINE TREATMENT OF PERIPHERAL T-CELL LYMPHOMAS DOES NOT IMPR... Read more
Clinical trials POLARIX: Pola-R-CHP versus R-CHOP in patients with previously untreated DLBCL Read more
Clinical trials Usage of younger unmatched donors for allo-HCT improves some clinical outcomes in MDS patients Read more
Clinical trials Asciminib as a new treatment option in later-line chronic myeloid leukaemia in chronic phase Read more
Clinical trials Betibeglogene autotemcel gene therapy for transfusion-dependent β-thalassemia Read more
Clinical trials Axicabtagene ciloleucel as second-line treatment for relapsed/refractory large B-cell lymphoma Read more
Clinical trials Addition of daratumumab to treatment is beneficial in newly diagnosed myeloma patients Read more
